Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ENDP

Endo

$9.50

0.05 (0.53%)

08:05
01/14/19
01/14
08:05
01/14/19
08:05
Recommendations
Endo analyst commentary at Canaccord »

Endo CCH asset remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$9.16

0.85 (10.23%)

15:27
01/07/19
01/07
15:27
01/07/19
15:27
Hot Stocks
Endo says focusing on strategic priority execution, plans on deleveraging »

Shares of specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

ENDP

Endo

$7.82

0.11 (1.43%)

13:35
01/03/19
01/03
13:35
01/03/19
13:35
Options
Endo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$7.43

0.12 (1.64%)

07:34
12/31/18
12/31
07:34
12/31/18
07:34
Hot Stocks
Endo: FDA requests further stay of Endo's ongoing litigation »

Endo International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

, ENDP

Endo

$9.45

(0.00%)

11:43
12/18/18
12/18
11:43
12/18/18
11:43
Hot Stocks
Catalyst Pharmaceuticals, Endo sign definitive agreement for vigabatrin tablets »

Catalyst Pharmaceuticals…

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

ENDP

Endo

$9.45

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$10.86

-0.27 (-2.43%)

, JNJ

Johnson & Johnson

$134.25

-13.55 (-9.17%)

13:37
12/14/18
12/14
13:37
12/14/18
13:37
Hot Stocks
60 Minutes to air feature on opiod fight this Sunday »

Mike Moore, the lawyer…

ENDP

Endo

$10.86

-0.27 (-2.43%)

JNJ

Johnson & Johnson

$134.25

-13.55 (-9.17%)

MCK

McKesson

$119.10

-3.76 (-3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$10.88

-0.25 (-2.25%)

13:35
12/14/18
12/14
13:35
12/14/18
13:35
Options
Endo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$21.11

0.16 (0.76%)

, ENDP

Endo

$11.45

0.23 (2.05%)

10:38
12/12/18
12/12
10:38
12/12/18
10:38
On The Fly
Mallinckrodt rises despite FDA failing to approve opioid painkiller »

Shares of Mallinckrodt…

MNK

Mallinckrodt

$21.11

0.16 (0.76%)

ENDP

Endo

$11.45

0.23 (2.05%)

JNJ

Johnson & Johnson

$148.10

1.58 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

ENDP

Endo

$11.20

-0.36 (-3.11%)

12:55
12/10/18
12/10
12:55
12/10/18
12:55
Options
Endo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$18.53

0.1 (0.54%)

, ENDP

Endo

$11.67

-0.975 (-7.71%)

08:40
11/27/18
11/27
08:40
11/27/18
08:40
Recommendations
Amneal Pharmaceuticals, Endo, Flexion, Jazz Pharmaceuticals analyst commentary at RBC Capital »

RBC Capital likes select…

AMRX

Amneal Pharmaceuticals

$18.53

0.1 (0.54%)

ENDP

Endo

$11.67

-0.975 (-7.71%)

FLXN

Flexion

$16.02

0.21 (1.33%)

JAZZ

Jazz Pharmaceuticals

$151.06

1.11 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 02

    Dec

  • 20

    Dec

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.